BOCA RATON, Fla.--Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today its concerns over metropolitan water systems. There have been recent public concerns in Colorado and Florida regarding failures in their metropolitan water systems. Many are due to the aging delivery systems that are breaking down at the point of entry or point of use, which results in high levels of contamination with pathogenic microorganisms. Although the most common contaminants will be organisms such as E. coli, Salmonella, or Pseudomonas, there has been a significant rise in organisms that are resistant to chlorine and related halogens such as fluorine and bromine. The general way that metropolitan water districts try to solve the problem is by flushing out the system and the introduction of high levels of free chlorine (a very toxic substance which is also corrosive to the pipes used to deliver water to the public).

"This extremely important disinfection technology developed by PRHB will provide an opportunity to address the concerns around the world on clean water. Recent public concerns over unacceptable contaminants in public water are increasing," said the Executive Producer of the Global News Group. "I am looking forward to presenting the story in an upcoming Special Edition report on this very important breakthrough."

In the recent past, there has been a significant increase in Cryptosporidium detected in public swimming pools throughout the country. Further, Noroviruses have entered the environment, namely on cruise ships. This means that infected individuals will continue to spread such pathogens and they will very likely enter the drinking water systems at increasing rates. Organisms such as Cryptosporidium, Giardia, and various viruses are virtually resistant to treatment with chlorine and other related halogens as well as chemicals such as pesticides and various prescription/over-the-counter pharmaceuticals. These organisms are not resistant to treatment with the SilverTTO which has been tested by Pure H2O Bio-technologies, Inc., (PRHB) in laboratory level studies and is now being verified with the state-of-the-art patent-pending treatment/delivery system that is underway. The system is also designed to remove chemical contaminants and metals that are present in source water. Certification of this system through EPA's contractor, National Sanitation Foundation (NSF) is expected to be completed within a few short months and has a high likelihood for success. This system will be available to individuals and hospitals as a system delivering "pathogen-free and chemical-free" water.

Pure H2O Bio-Technologies, Inc., www.pureh20biotech.com, has been developing a water treatment system designed to kill the pathogenic microbes such as those cited above and to deliver highly purified water at the point-of-entry (POE) and point-of-use (POU), namely for residential, commercial, hospital and medical facilities. "Our potable water disinfection systems, in the near-final and certification testing stages, can provide both disinfection and purification of the contaminated water. On July 31, 2007, the Company was awarded patent #7250111, and two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C.," stated Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc.


[ Read the rest ... ]

BOCA RATON, Fla.--Pure H20 Bio-Technologies, Inc. (Pink Sheets:PRHB), today announces confirmation of New Stock Symbol PRHB and Reverse Split of its Common Stock. The Company’s stock transfer agent, Continental Stock Transfer and Trust Company, located at 17 Battery Place, New York, New York, is the Exchange Agent for its approved reverse split of the Company's Common Stock. On March 3, 2008 the company filed a 1-for-4,500 (1:4,500) reverse stock split of the Company's Common Stock. The reverse split became effective today upon the filing of the company's Certificate of Amendment to the Articles of Incorporation of Pure H20 Bio-Technologies, Inc., with the Florida Secretary of State.

The reorganization will be effective at the open of the market today and the new stock symbol is "PRHB" and the Cusip Number is: 746223 40 3. The distribution of the post-split common shares are payable upon surrender of the pre-split common shares.

"For each forty-five hundred (4,500) shares of pre-split common stock held a shareholder will receive one (1) share of post-split common stock. No fractional shares or script representing fractions of a share shall be issued, but in lieu thereof, each fraction of a share that any Stockholder would otherwise be entitled to receive shall be rounded up to the nearest whole share and no additional script or payment made," as stated in the Company's Articles of Amendment.



[ Read the rest ... ]

BOCA RATON, Fla.--(BUSINESS WIRE)--Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHN) announces its decision by the Board of Directors to rescind its recent forward split of its common shares as to the intended effective date November 30th 2007. NASDAQ Stock Market Data Operations, Connecticut, as well as Continental Stock Transfer and Trust Company, New York, N.Y. has been notified and advised. The Board based its decision on an unforeseeable delay in the processing of the necessary documentation due to the Thanksgiving holiday to make the November 30th deadline.

“The Company apologizes for the delay and will revisit this issue in the future,” said Joseph P. Doxey, President


[ Read the rest ... ]

BOCA RATON, Fla.--(BUSINESS WIRE)--Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHN) is pleased to announce that phase II of construction for the Company's manufacturing facility has been completed. Phase III of the building process is currently in progress by Brian Wight Construction, Inc., and the Company expects the facility to be completed by the end of the current quarter.

Pure H20 will utilize the facility to manufacture the Company's potable water disinfection systems. During Phase III of the building process, the equipment to produce the Company's residential, commercial and hospital water disinfection systems will be installed. Photos of phase I are currently available and Phase II are forthcoming on the Company's Web site.

"We have been working diligently with our construction company to complete the project on time. We expect to have our facility up and running by the end of the year. It is an exciting time for our Company as we see the progress of completing the facility," stated Joseph P. Doxey, President of Pure H20 Bio-Technologies, Inc.

The Company recently announced to all shareholders that the Board approved a 1 for 1 forward split of all issued and outstanding shares. The ratio of the distribution will be one share for every share that is held as of the record date. The record date for the forward split will be this Friday, November 30, 2007.

[ Read the rest ... ]

BOCA RATON, Fla.--(BUSINESS WIRE)--Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHN) announced today its concerns over recent boil water alerts.

Serious problems with microbial contamination of municipal drinking water have occurred recently in many communities at alarming frequencies. An example of this problem is that of a south Florida water system which occurred within the past month and again less than a week ago. This resulted in a "Boil Water" alert to the affected communities. This problem has been occurring nationwide due to aging water distribution systems. The problem is not due to inadequacies of water treatment plants, but to the breach of the distribution of treated waters at the point-of-entry (POE) and point-of-use (POU). This means that the consumer is at high risk of infection from waterborne pathogens such as E.coli, Cryptosporidium, and Noroviruses, which are introduced through fecal sources, such as sewage and contaminated storm water overflows or direct breaches in the sewer and water distribution pipes. These concerns have been expressed in various documents prepared by the US Environmental Protection Agency (EPA), American Waterworks Association (AWWA), and the Water Environment Research Foundation (WERF).

Pure H2O Bio-Technologies, Inc., www.pureh20biotech.com, has been developing a water treatment system designed to kill the pathogenic microbes such as those cited above and to deliver highly purified water at the POE and POU, namely for residential, commercial, hospital and medical facilities.

“Our potable water disinfection systems, that are in the near-final and certification testing stages, can provide both disinfection and purification of the water so that the necessity to boil water is potentially eliminated," stated Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc.



[ Read the rest ... ]

BOCA RATON, Fla.--(BUSINESS WIRE)--Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHN) is pleased to announces a 1 for 1 forward split of all issued and outstanding common shares of Pure H20 Bio-Technologies, Inc. The ratio of the distribution will be one common share for every one common share that is held. The record date for all shareholders of record will be November 30th, 2007. NASDAQ Stock Market Data Operations, Connecticut, as well as Continental Stock Transfer and Trust Company, New York, N.Y. have been notified and advised.

The Company has achieved several milestones in previous months. The Company received final approval and issuance on July 31, 2007 from the United States Patent and Trademark Office, Washington, D.C., on one of its three patent applications, two of which are pending in the fields of micro-biotechnology and engineering, for its potable water disinfection systems. Additionally, the Company has broken ground and completed phase one of its new manufacturing facility located in Georgia. It engaged Brian Wight Construction Company, Inc. to complete phase two of the project, which is tentatively scheduled for mid-December. Pure H20 has also engaged Special Report TV and other public relations agencies to implement marketing and promotional campaigns to bolster its asset base.

"We have made tremendous strides in combating waterborne disease. Our professional team of micro-biologists and engineers, along with highly respected scientists at Genapure Analytical Services, Inc., formerly US Bio-Systems, Clancy Environmental Consultants, Inc., Environmental Protection Agency (EPA) and National Sanitation Foundation (NSF) have worked diligently to help us achieve the progress we have made so far. In turn, we want to thank our shareholders for their continued support and their belief in our dedication in pursing the science of killing micro-organisms in water; therefore, on behalf of Pure H2O Bio-Technologies, Inc., we are giving our shareholders a token of our thanks by issuing additional shares in the form of a forward split. We believe the forward split will positively impact the Company's overall growth by rewarding our loyal shareholders," stated Joseph P. Doxey, President of Pure H20 Bio-Technologies, Inc.


[ Read the rest ... ]

Marketing Firms to Assist Company to Increase Its Asset Base

BOCA RATON, Fla.--(BUSINESS WIRE)--Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHN) is pleased to announce that the Company has begun implementing its marketing strategy to current and potential investors by engaging several large marketing firms. Over the last several months, Pure H20's marketing focus has shifted toward increasing its asset and shareholder base.

Pure H2O is currently working with several marketing firms to assist the Company in its effort to provide additional exposure about the Company to a broader market including, but not limited to, the medical industry. Pure H20 Bio-Technologies has recently completed phase one of its manufacturing facility for its potable water disinfection systems. The Company recently received final approval from the U.S. Patent and Trademark office for its potable water disinfection system to deliver safe clean drinking water.

"We believe the marketing firms we engaged will effectively represent Pure H2O by keeping the current and potential shareholders informed on the progress of the Company," stated Joseph Doxey, CEO of Pure H20 Bio-Technologies, Inc.

[ Read the rest ... ]